Bing

SEARCH HISTORY

[Reuters] – Eli Lilly and Co on Monday said it would continue a large study of its high-profile experimental drug to raise “good” HDL cholesterol and lower “bad” LDL cholesterol, acting on the recommendation of a …
Jutia Group · 1 day ago
HDL cholesterol
Eli Lilly and (NYSE:LLY) was upgraded by Zacks from a “hold” rating to a “buy” rating in a research report issued on Tuesday, AnalystRatings.NET reports. The firm currently has a $94.00 price objective on the stock. Zacks‘s price target suggests ...
Ticker Report · 1 hour ago
One stock that warrants investor consideration out of these industries is Eli Lilly & Co. (LLY - Analyst Report), a large cap pharmaceutical company that currently has the potential to produce significant gains in the near future based on trends and data ...
ZACKS · 48 minutes ago
Warrants Attention
More from Bing News
Eli Lilly and Co (NYSE:LLY) stock declined significantly in Wednesday’s trading, after Morgan Stanley downgraded it from an Overweight to Equal Weight and reiterated a price target of $93. The cause involved …
bidnessetc.com · 7/17/2015
Eli Lilly
NEW YORK (TheStreet) -- BMO Capital Markets raised its price target for Eli Lilly (LLY - Get Report) to $92 from $74 on Thursday, reiterating its "market perform" rating for the drug manufacturer. The analyst firm raised …
The Street · 7/16/2015
Eli Lilly and (NYSE:LLY)‘s stock had its “buy” rating reiterated by investment analysts at Leerink Swann in a note issued to investors on Wednesday, AnalystRatingsNetwork.com reports. They currently have a $92.00 price objective on the stock.
Mideast Times · 7/24/2015
Eli Lilly and (NYSE:LLY) had its cost target upped by SunTrust from $95.00 to $98.00 in a research note issued to investors on Monday, Marketbeat.com reports. The firm currently has a buy rating about the stock. Several other equities research analysts ...
sleekmoney.com · 1 hour ago
Eli Lilly (NYSE:LLY) defies analysts with a current price ($84.70) 5.5% above its average consensus price target of $80.00. The stock should discover initial support at its 50-day moving average (MA) of $82.37 and subsequent support at its 200-day MA of $ ...
Financial News Network Online · ByMallory Stone · 4 hours ago
Eli Lilly
Teva Pharmaceutical Industries Ltd. on Monday said it would buy Allergan PLC’s generics unit for $40.5 billion in cash and stock, in a deal that will vault ... such as Cialis maker Eli Lilly & Co. LLY, -2.35% , which …
Market Watch · 1 day ago
Allergan Generics
"I'd rather be long in the stock here," he said. Long AMAT, AAPL, BAC, BMY, BP, CSX, DISCA, DKS, FOXA, GE, KKR, KO, LLY, MRK, PEP, PFE, he is long calls AAPL, AGNC, AMKR, AXP, BAC, C, CRM, CY, DAL …
CNBC · 19 hours ago
Internet earnings

Eli Lilly and Company

Company
Eli Lilly and Company is an American global pharmaceutical company with headquarters located in Indianapolis, Indiana, in t…
Eli Lilly and Company is an American global pharmaceutical company with headquarters located in Indianapolis, Indiana, in the United States. The company also has offices in Puerto Rico and 17 other countries. Their products are sold in approximately 125 countries. The company was founded in 1876 by Col. Eli Lilly, a pharmaceutical chemist and veteran of the American Civil War, after whom the company was named.
Data from: Wikipedia · Freebase